Enzo Biochem Inc
ENZBDelisted Apr 7, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Enzo Biochem Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- −5 vs. Q2 2022
- Shares held
- 20.5M
- −627.2K (−3.0%) vs. Q2 2022
- Total value
- $45.6M
- +$1.85M (+4.2%) vs. Q2 2022
- New holders
- 2
- 6 more added
- Sold out
- 7
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 7 | $2.00M |
| Q1 2025 | 41 | $4.96M |
| Q4 2024 | 44 | $9.71M |
| Q3 2024 | 43 | $14.2M |
| Q2 2024 | 39 | $13.5M |
| Q1 2024 | 41 | $17.6M |
| Q4 2023 | 46 | $22.7M |
| Q3 2023 | 39 | $23.1M |
| Q2 2023 | 47 | $34.7M |
| Q1 2023 | 52 | $48.1M |
| Q4 2022 | 52 | $26.8M |
| Q3 2022 | 49 | $45.6M |
| Q2 2022 | 54 | $43.8M |
| Q1 2022 | 51 | $62.0M |
| Q4 2021 | 59 | $69.0M |
| Q3 2021 | 65 | $82.9M |
| Q2 2021 | 72 | $76.6M |
| Q1 2021 | 82 | $94.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harbert Fund Advisors, Inc. | 5,175,913 | $11.5M | 9.21% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,909,664 | $6.49M | 0.01% | −106,500−3.5% | Reduced |
| Roumell Asset Management, LLC | 2,390,211 | $5.33M | 11.54% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,770,749 | $3.95M | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,593,865 | $3.55M | 0.00% | −8,510−0.5% | Reduced |
| BlackRock Inc. | 1,468,121 | $3.27M | 0.00% | −62,134−4.1% | Reduced |
| VIEX Capital Advisors, LLC | 1,334,479 | $2.98M | 10.01% | −202,378−13.2% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 971,010 | $2.17M | 0.02% | +13,525+1.4% | Added |
| Potomac Capital Management, Inc. | 559,500 | $1.25M | 1.74% | 00.0% | Unchanged |
| Morgan Stanley | 389,198 | $867.0K | 0.00% | −31,558−7.5% | Reduced |
| Geode Capital Management, LLC | 357,544 | $797.0K | 0.00% | +977+0.3% | Added |
| Bridgeway Capital Management, LLC | 320,700 | $715.0K | 0.02% | −55,000−14.6% | Reduced |
| RBF Capital, LLC | 250,359 | $559.0K | 0.05% | 00.0% | Unchanged |
| State Street Corp | 185,639 | $414.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 104,068 | $232.0K | 0.00% | −7,026−6.3% | Reduced |
| Bank of New York Mellon Corp | 87,281 | $194.0K | 0.00% | +1,998+2.3% | Added |
| Corsair Capital Management, L.P. | 75,049 | $167.0K | 0.07% | +230.0% | Added |
| SNS Financial Group, LLC | 62,500 | $139.0K | 0.02% | 00.0% | Unchanged |
| Group One Trading, L.P. | 51,594 | $115.0K | 0.00% | +51,594 | New |
| Truist Financial Corp | 50,016 | $112.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 44,800 | $100.0K | 0.00% | 00.0% | Unchanged |
| Snowden Capital Advisors LLC | 31,704 | $70.0K | 0.00% | −1,350−4.1% | Reduced |
| Simplex Trading, LLC | 27,731 | $61.0K | 0.00% | +14,954+117.0% | Added |
| Tower Research Capital LLC (TRC) | 25,832 | $57.0K | 0.00% | −6,960−21.2% | Reduced |
| Kempner Capital Management Inc. | 25,475 | $57.0K | 0.04% | 00.0% | Unchanged |
| Cutter & CO Brokerage, Inc. | 21,777 | $49.0K | 0.02% | 00.0% | Unchanged |
| AE Wealth Management LLC | 20,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| Paradigm Financial Partners, LLC | 18,000 | $41.0K | 0.01% | 00.0% | Unchanged |
| Prudential Financial Inc | 18,200 | $41.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,191 | $40.0K | 0.00% | −10,274−36.1% | Reduced |
| Goldman Sachs Group Inc | 17,473 | $39.0K | 0.00% | −3,649−17.3% | Reduced |
| Raymond James Trust N.A. | 17,016 | $38.0K | 0.00% | 00.0% | Unchanged |
| Shulman DeMeo Asset Management LLC | 15,487 | $35.0K | 0.01% | +15,487 | New |
| Baird Financial Group, Inc. | 15,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,471 | $31.0K | 0.00% | 00.0% | Unchanged |
| Wealth Alliance | 11,433 | $25.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,029 | $13.0K | 0.00% | 00.0% | Unchanged |
| BDO Wealth Advisors, LLC | 5,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,456 | $3.00K | 0.00% | +371+34.2% | Added |
| Advisor Group Holdings, Inc. | 728 | $2.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 518 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Benjamin Edwards Inc | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 70 | $0 | 0.00% | 00.0% | Unchanged |
| City Holding Co | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 242 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 110 | $0 | 0.00% | 00.0% | Unchanged |
| FourThought Financial, LLC | 217 | $0 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 132 | – | – | 00.0% | Unchanged |
| Veritable, L.P. | 0 | $0 | 0.00% | −99,675−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −45,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,133−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −21,943−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −19,603−100.0% | Sold out |
| Shufro Rose & Co LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −425−100.0% | Sold out |